Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea

Next Previous
X
Search
Trial Profile

A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Surotomycin (Primary) ; Vancomycin
  • Indications Clostridium difficile infections; Diarrhoea; Intestinal infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms C-difficile
  • Sponsors Cubist Pharmaceuticals

    • Most Recent Events

    • 03 Aug 2020 Results of a pooled analysis of the data from the two phase III trials (NCT01597505 and NCT01598311) assessing the molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile isolates from patients with C. difficile infection, published in the Journal of Antimicrobial Chemotherapy
    • 26 Feb 2018 A protocol has been amended with addition of primary safety endpoints and change in secondary endpoints.
    • 12 Apr 2016 Results assessing susceptibility and molecular epidemiology of Clostridium difficile presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top